Closing Bell Report

|
Jittery investors wary of rising oil prices and disappointing earnings sold off to send the market plummeting to a sharply lower close with the Dow collapsing 240 points to 11,131.  Nasdaq skidded 46 points to 2264.

On the upside

Sunoco (NYSE: SUN) restarted a crude unit at its Eagle Point refinery that had shut down when power was lost.

BioCryst Pharmaceuticals (Nasdaq: BCRX) reported that its injectible flu treatment met the goals of a midstage clinical trial.

EnergySouth (Nasdaq: ENSI) agreed to be acquired by Sempra Energy (NYSE: SRE) for approximately $510 million in cash.

On the downside

Mylan's (NYSE: MYL) generic version of Sciele Pharma's (Nasdaq: SCRX) blood pressure treatment Sular was approved by the Food and Drug Administration.

Renewed concerns about the stability of the financial services sector sent shares of Merrill Lynch (Nasdaq: MER) tumbling.

Insurance industry earnings concerns weighed down shares of American International Group (NYSE: AIG).


In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by nearly 3 to 1 on Nasdaq.  The Russell 2000 which tracks small cap stocks skidded 14 points to 696.

About this Entry

This page contains a single entry by published on July 28, 2008 1:43 PM.

Mid-Day Report was the previous entry in this blog.

Opening Bell Report is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12